10．骨髄腫類縁疾患の診断と治療の進歩
Saved in:
| Published in | 日本内科学会雑誌 Vol. 108; no. 9; pp. 1926 - 1933 |
|---|---|
| Main Author | |
| Format | Journal Article |
| Language | Japanese |
| Published |
一般社団法人 日本内科学会
10.09.2019
|
| Subjects | |
| Online Access | Get full text |
| ISSN | 0021-5384 1883-2083 |
| DOI | 10.2169/naika.108.1926 |
Cover
| Author | 矢野, 真吾 |
|---|---|
| Author_xml | – sequence: 1 fullname: 矢野, 真吾 organization: 東京慈恵会医科大学腫瘍・血液内科 |
| BookMark | eNo9j79Lw0AcxQ-pYKxd_S8S70dyuYxa_AUFF52P712umlijJF3cbNHVseAiiEu01KGTqPjPFJJm8l8wVnF5j_cePPisokZynhiE1gl2KOHBRgLRKTgEC4cElC8hiwjBbIoFayALY0psjwl3BbWyLFLYZdwThLkW8gj--ritnvNqfD2_GVcP9-XroBx9FsPH2eBlnr8Vo8lskBfT9_JuWDfV1bSYPK2h5S70MtP68yY62tk-bO_ZnYPd_fZmx46JJwLbF9zXRDETcuwrHug6e4JRg1XItauI9hnVoLQRjAUYA4Tcp-C6vlLCgy5roq3f3zjrw7GRF2l0BumlhLQf6Z6RC2pZU8tgoT_s_6M-gVTGwL4BF4dm_g |
| ContentType | Journal Article |
| Copyright | 2019 一般社団法人 日本内科学会 |
| Copyright_xml | – notice: 2019 一般社団法人 日本内科学会 |
| DOI | 10.2169/naika.108.1926 |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine |
| EISSN | 1883-2083 |
| EndPage | 1933 |
| ExternalDocumentID | article_naika_108_9_108_1926_article_char_ja |
| GroupedDBID | ALMA_UNASSIGNED_HOLDINGS DIK F5P JSF OK1 RJT |
| ID | FETCH-LOGICAL-j1589-7867c1b3ed607b69c8675832e0bd6c4b1c732cabce833900aad672a447bb85af3 |
| ISSN | 0021-5384 |
| IngestDate | Wed Sep 03 06:30:12 EDT 2025 |
| IsDoiOpenAccess | true |
| IsOpenAccess | true |
| IsPeerReviewed | false |
| IsScholarly | true |
| Issue | 9 |
| Language | Japanese |
| LinkModel | OpenURL |
| MergedId | FETCHMERGED-LOGICAL-j1589-7867c1b3ed607b69c8675832e0bd6c4b1c732cabce833900aad672a447bb85af3 |
| OpenAccessLink | https://www.jstage.jst.go.jp/article/naika/108/9/108_1926/_article/-char/ja |
| PageCount | 8 |
| ParticipantIDs | jstage_primary_article_naika_108_9_108_1926_article_char_ja |
| PublicationCentury | 2000 |
| PublicationDate | 2019/09/10 |
| PublicationDateYYYYMMDD | 2019-09-10 |
| PublicationDate_xml | – month: 09 year: 2019 text: 2019/09/10 day: 10 |
| PublicationDecade | 2010 |
| PublicationTitle | 日本内科学会雑誌 |
| PublicationTitleAlternate | 日内会誌 |
| PublicationYear | 2019 |
| Publisher | 一般社団法人 日本内科学会 |
| Publisher_xml | – name: 一般社団法人 日本内科学会 |
| References | 7) Kuwabara S, et al: Thalidomide reduces serum VEGF levels and improves peripheral neuropathy in POEMS syndrome. J Neurol Neurosurg Psychiatry 79: 1255-1257, 2008. 5) Kuwabara S, et al: Long term melphalan-prednisolone chemotherapy for POEMS syndrome. J Neurol Neurosurg Psychiatry 63: 385-387, 1997. 14) Palladini G, et al: Association of melphalan and high-dose dexamethasone is effective and well tolerated in patients with AL (primary) amyloidosis who are ineligible for stem cell transplantation. Blood 103: 2936-2938, 2004. 2) Dispenzieri A: POEMS syndrome: 2017 update on diagnosis, risk stratification, and management. Am J Hematol 92: 814-829, 2017. 6) Li J, et al: Combination of melphalan and dexamethasone for patients with newly diagnosed POEMS syndrome. Blood 117: 6445-6449, 2011. 12) Jaccard A, et al: High-dose melphalan versus melphalan plus dexamethasone for AL amyloidosis. N Engl J Med 357: 1083-1093, 2007. 15) Palladini G, et al: Oral melphalan and dexamethasone grants extended survival with minimal toxicity in AL amyloidosis: long-term results of a risk-adapted approach. Haematologica 99: 743-750, 2014. 8) Misawa S, et al: Safety and efficacy of thalidomide in patients with POEMS syndrome: a multicentre, randomised, double-blind, placebo-controlled trial. Lancet Neurol 15: 1129-1137, 2016. 4) Dispenzieri A, et al: Peripheral blood stem cell transplant for POEMS syndrome is associated with high rates of engraftment syndrome. Eur J Haematol 80: 397-406, 2008. 3) Ohwada C, et al: Long-term evaluation of physical improvement and survival of autologous stem cell transplantation in POEMS syndrome. Blood 131: 2173-2176, 2018. 13) Sidiqi MH, et al: Stem cell transplantation for light chain amyloidosis: decreased early mortality over time. J Clin Oncol 36: 1323-1329, 2018. 11) 安東由喜雄監修: 最新アミロイドーシスのすべて 診療ガイドライン2017とQ&A. 植田光晴編. 医歯薬出版, 東京, 2017. 1) 桑原 聡: Crow-Fukase症候群の病態と新規治療. 日内会誌 100: 2275-2281, 2011. 10) He H, et al: Successful treatment of newly diagnosed POEMS syndrome with reduced-dose bortezomib based regimen. Br J Haematol 181: 126-128, 2018. 9) Li J, et al: A prospective phase II study of low dose lenalidomide plus dexamethasone in patients with newly diagnosed polyneuropathy, organomegaly, endocrinopathy, monoclonal gammopathy, and skin changes (POEMS) syndrome. Am J Hematol 93: 803-809, 2018. |
| References_xml | – reference: 6) Li J, et al: Combination of melphalan and dexamethasone for patients with newly diagnosed POEMS syndrome. Blood 117: 6445-6449, 2011. – reference: 15) Palladini G, et al: Oral melphalan and dexamethasone grants extended survival with minimal toxicity in AL amyloidosis: long-term results of a risk-adapted approach. Haematologica 99: 743-750, 2014. – reference: 8) Misawa S, et al: Safety and efficacy of thalidomide in patients with POEMS syndrome: a multicentre, randomised, double-blind, placebo-controlled trial. Lancet Neurol 15: 1129-1137, 2016. – reference: 14) Palladini G, et al: Association of melphalan and high-dose dexamethasone is effective and well tolerated in patients with AL (primary) amyloidosis who are ineligible for stem cell transplantation. Blood 103: 2936-2938, 2004. – reference: 3) Ohwada C, et al: Long-term evaluation of physical improvement and survival of autologous stem cell transplantation in POEMS syndrome. Blood 131: 2173-2176, 2018. – reference: 7) Kuwabara S, et al: Thalidomide reduces serum VEGF levels and improves peripheral neuropathy in POEMS syndrome. J Neurol Neurosurg Psychiatry 79: 1255-1257, 2008. – reference: 9) Li J, et al: A prospective phase II study of low dose lenalidomide plus dexamethasone in patients with newly diagnosed polyneuropathy, organomegaly, endocrinopathy, monoclonal gammopathy, and skin changes (POEMS) syndrome. Am J Hematol 93: 803-809, 2018. – reference: 13) Sidiqi MH, et al: Stem cell transplantation for light chain amyloidosis: decreased early mortality over time. J Clin Oncol 36: 1323-1329, 2018. – reference: 4) Dispenzieri A, et al: Peripheral blood stem cell transplant for POEMS syndrome is associated with high rates of engraftment syndrome. Eur J Haematol 80: 397-406, 2008. – reference: 10) He H, et al: Successful treatment of newly diagnosed POEMS syndrome with reduced-dose bortezomib based regimen. Br J Haematol 181: 126-128, 2018. – reference: 12) Jaccard A, et al: High-dose melphalan versus melphalan plus dexamethasone for AL amyloidosis. N Engl J Med 357: 1083-1093, 2007. – reference: 2) Dispenzieri A: POEMS syndrome: 2017 update on diagnosis, risk stratification, and management. Am J Hematol 92: 814-829, 2017. – reference: 5) Kuwabara S, et al: Long term melphalan-prednisolone chemotherapy for POEMS syndrome. J Neurol Neurosurg Psychiatry 63: 385-387, 1997. – reference: 11) 安東由喜雄監修: 最新アミロイドーシスのすべて 診療ガイドライン2017とQ&A. 植田光晴編. 医歯薬出版, 東京, 2017. – reference: 1) 桑原 聡: Crow-Fukase症候群の病態と新規治療. 日内会誌 100: 2275-2281, 2011. |
| SSID | ssib043658134 ssj0066765 ssib002821954 ssib005879745 ssib007485360 ssib058493862 ssib000940260 ssib002484664 |
| Score | 2.1887338 |
| SourceID | jstage |
| SourceType | Publisher |
| StartPage | 1926 |
| SubjectTerms | ALアミロイドーシス POEMS症候群 骨髄類縁疾患 |
| Title | 10．骨髄腫類縁疾患の診断と治療の進歩 |
| URI | https://www.jstage.jst.go.jp/article/naika/108/9/108_1926/_article/-char/ja |
| Volume | 108 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| ispartofPNX | 日本内科学会雑誌, 2019/09/10, Vol.108(9), pp.1926-1933 |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV3NaxQxFB9qBfEifuI3PZiTTJ1MZpIXvJhZZylKBaGF3obJ7OxhD1uR9eLJLXr1WPAiiJfVUg89iYr_TGG3e_Jf8L3MfsxCD7bCMmRf8l7y8jLJL8PLi-fdU0VoBReRH5a69KNICT-3cduXRSTyNgieu3vI1p_Jtc3oyVa8tXTmUf10Sc-uFq-PPVdyGqsiDe1Kp2RPYNmZUCRgGu2LT7QwPv_JxjxgaZMlDQYpSzUzhhlwiYRBxFJgEFOaKJxpLKNYgkROCS1ZghTJIGRGsFQQ3aTEhUISQ1lYxjyeZgFRkpAliWPXxDjn0uQygbmpYzG6DnqdKMVM7BINZhosjRlIah6KMiiNE4UYJUsj0kgbkqkTlwWkGsy-57r6m8yErlpF2uNAcdQGZaAojY1J6180uHPZmvi20hh09QC1mvoJXKOwLZHrlZhqpl5BjQXTsSts8Hf_dLrU14aQ-zj9V583ymo5ABA44qqrdmbrRQC1F0PXZn9Ey7KGJBAbi-NWqZBLCvLapTNi5OO5OudbiPw9GVeZK0iRXDPtnlQ8m2bS4bysgzuEs6FSzlHh6fMawNYRBY2rATJYuE8AN9y8HhAwBqXr9x-oCOHcnD8SCFj5PKAgolctQM4CtpHDdHVnyKQvqzCppPCDRXUR8HVw-zN1nXRobuOid2GyDVsxlXqXvKVOftk7tz5xNLni4Rry59f78dfBeO_t0bu98aePo-_90e7v4c7nw_63o8GP4e7-YX8wPPg5-rCDlPGbg-H-l6veZjPdaKz5kxtG_A6PQfsKpCq4FWVLBspKXQDtn0VYBraFs5XlhRJhkduiBCF0EOR5S6owxynNWojztrjmLXe3u-V1b0VJi1DB0n4BOyUMNP7B1VPEObSVVfaG97BSOHtRhZHJTmLem__Ffcs7P3_PbnvLvZevyjuIpXv2rhsufwEzLZ5- |
| linkProvider | Colorado Alliance of Research Libraries |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=10%EF%BC%8E%E9%AA%A8%E9%AB%84%E8%85%AB%E9%A1%9E%E7%B8%81%E7%96%BE%E6%82%A3%E3%81%AE%E8%A8%BA%E6%96%AD%E3%81%A8%E6%B2%BB%E7%99%82%E3%81%AE%E9%80%B2%E6%AD%A9&rft.jtitle=%E6%97%A5%E6%9C%AC%E5%86%85%E7%A7%91%E5%AD%A6%E4%BC%9A%E9%9B%91%E8%AA%8C&rft.au=%E7%9F%A2%E9%87%8E%2C+%E7%9C%9F%E5%90%BE&rft.date=2019-09-10&rft.pub=%E4%B8%80%E8%88%AC%E7%A4%BE%E5%9B%A3%E6%B3%95%E4%BA%BA+%E6%97%A5%E6%9C%AC%E5%86%85%E7%A7%91%E5%AD%A6%E4%BC%9A&rft.issn=0021-5384&rft.eissn=1883-2083&rft.volume=108&rft.issue=9&rft.spage=1926&rft.epage=1933&rft_id=info:doi/10.2169%2Fnaika.108.1926&rft.externalDocID=article_naika_108_9_108_1926_article_char_ja |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0021-5384&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0021-5384&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0021-5384&client=summon |